Valproic Acid Solution
Product Images NDC 81033-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 81033-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kesin Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line chart comparing the percentage reduction in CPS rate between patients treated with Divalproex Sodium and those given a placebo. The x-axis represents the percentage of patients, while the y-axis shows the percent reduction in CPS rate, ranging from worsening to improvement. Two lines illustrate the treatment effect, with Divalproex Sodium showing greater improvement than placebo.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A cumulative distribution plot showing percent reduction in CPS rate on the vertical axis versus percent of patients on the horizontal axis, comparing high dose (solid line) and low dose (dotted line) groups. The graph indicates patient improvement or worsening in CPS rate, with improvement upward and worsening downward, demonstrating response distribution by dose level.*
FDA Label Image
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Valproic Acid showing its molecular arrangement with carbon (CH3 and CH2 groups), a central CH, and a carboxyl group (C=O and OH).*
FDA Label Image

Table 1. Initial Daily Dose (Table 1)

Table 1. Initial Daily Dose (Table 1)
A data table titled 'Initial Daily Dose' showing weight ranges in kilograms and pounds, corresponding total daily doses in milligrams, and doses of oral solution in teaspoons divided into Dose 1, Dose 2, and Dose 3 columns. The table relates weight categories to dosing amounts for Valproic Acid oral solution.*
FDA Label Image

Valproic Acid 10 mL Case Label 100 Count (Valproic Os Case Label 10ml 100ct Image)

Valproic Acid 10 mL Case Label 100 Count (Valproic Os Case Label 10ml 100ct Image)
Label for Valproic Acid Oral Solution, USP 500 mg/10 mL by Kesin Pharma Corporation. The label indicates a 10 mL delivery volume with case packaging of 100 unit-dose cups. Storage instructions specify 68°F to 77°F (20°C to 25°C). The label includes multiple barcodes, an Rx Only marking, and a logo for Kesin Pharma Corporation in Oldsmar, FL.*
FDA Label Image

Valproic Acid 5 mL Case Label 100 Count (Valproic Os Case Label 5ml 100ct Image)

Valproic Acid 5 mL Case Label 100 Count (Valproic Os Case Label 5ml 100ct Image)
Label for Valproic Acid Oral Solution, USP 250 mg/5 mL by Kesin Pharma Corporation. The product is an oral solution packaged as 5 mL unit dose cups, with 100 cups per case. The label includes storage instructions (68°F to 77°F), barcodes, NDC 81033-266-50, and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.